Storyboard

Potential fourth COVID-19 vaccine in US

Biotech company Novavax says its COVID-19 vaccine has shown to be highly effective in clinical trials, which puts it on track to become the fourth vaccine available in the United States.

Avatar - ABC News
Curated by
ABC News
    • Coronavirus (COVID-19)
    • COVID-19 Vaccines
    • COVID-19 Testing
    • Public Health
    • Pandemics
Potential fourth COVID-19 vaccine in US
Continue to read
9 stories in this Storyboard
    Novavax announces its COVID-19 vaccine is over 90% effective against symptomatic disease

    Novavax announces its COVID-19 vaccine is over 90% effective against symptomatic disease

    The vaccine also provided 100% protection against moderate and severe disease. LONDON -- American biotechnology company Novavax announced Monday that …

More stories from Coronavirus (COVID-19)